Wednesday, February 26, 2020

February 26, 2020 Pioneer Drug Maker Throws First Punch At Pharmacy Outsourcing Facilities (503b)

"Azurity Pharmaceuticals, Inc. — a pioneer drug company that markets its FDA-approved oral vancomycin hydrochloride solution, FIRVANQ® — has sued Edge Pharma, LLC, an outsourcing facility operating pursuant to section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA), for compounding an oral vancomycin hydrochloride solution that is identical or nearly identical to FIRVANQ."  More Here

No comments: